Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40,762,262
-
Total 13F shares
-
25,854,693
-
Share change
-
+4,250,898
-
Total reported value
-
$1,140,627,052
-
Price per share
-
$44.12
-
Number of holders
-
114
-
Value change
-
+$183,972,667
-
Number of buys
-
81
-
Number of sells
-
51
Institutional Holders of Pulmonx Corp - COM (LUNG) as of Q2 2021
As of 30 Jun 2021 Pulmonx Corp - COM (LUNG) had 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 25,854,693 shares of stock of the company.
Largest 10 holders included Capital World Investors, BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), RTW INVESTMENTS, LP, Champlain Investment Partners, LLC, GILDER GAGNON HOWE & CO LLC, KPCB XIII Associates, LLC, and Point72 Asset Management, L.P..
This table shows 112 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.